The NIMH-CATIE Schizophrenia Study: What Did We Learn?
- 1 August 2011
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 168 (8), 770-775
- https://doi.org/10.1176/appi.ajp.2011.11010039
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Clinical Trials Design Lessons From the CATIE StudyAmerican Journal of Psychiatry, 2009
- A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of SchizophreniaAmerican Journal of Psychiatry, 2009
- Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysisThe Lancet, 2009
- Double-Blind Comparison of First- and Second-Generation Antipsychotics in Early-Onset Schizophrenia and Schizo-affective Disorder: Findings From the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) StudyAmerican Journal of Psychiatry, 2008
- World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophreniaSchizophrenia Research, 2008
- CATIE and CUtLASS: can we handle the truth?The British Journal of Psychiatry, 2008
- Commentary on the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE).Published by Physicians Postgraduate Press, Inc ,2006
- Why Olanzapine Beats Risperidone, Risperidone Beats Quetiapine, and Quetiapine Beats Olanzapine: An Exploratory Analysis of Head-to-Head Comparison Studies of Second-Generation AntipsychoticsAmerican Journal of Psychiatry, 2006
- Effectiveness of Antipsychotic Drugs in Patients with Chronic SchizophreniaThe New England Journal of Medicine, 2005
- Trends in the Rate and Type of Antipsychotic Medications Prescribed to Persons With SchizophreniaSchizophrenia Bulletin, 2003